Education
About Us
Working with TipRanks
Follow Us
Theraclion SA (TCLIF)
OTHER OTC:TCLIF
TCLIF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.32 - $0.59
Previous CloseN/A
Volume1.00K
Average Volume (3M)0.00
Market Cap
$9.05M
Enterprise Value$11.96M
Total Cash (Recent Filing)€907.77K
Total Debt (Recent Filing)€6.16M
Price to Earnings (P/E)―
Beta1.39
Next Earnings
Apr 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)21.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
TCLIF FAQ
What was Theraclion SA’s price range in the past 12 months?
Theraclion SA lowest stock price was $0.32 and its highest was $0.59 in the past 12 months.
What is Theraclion SA’s market cap?
Theraclion SA’s market cap is $9.05M.
When is Theraclion SA’s upcoming earnings report date?
Theraclion SA’s upcoming earnings report date is Apr 29, 2025 which is in 30 days.
How were Theraclion SA’s earnings last quarter?
Theraclion SA released its earnings results on Oct 30, 2024. The company reported -$0.056 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.056.
Is Theraclion SA overvalued?
According to Wall Street analysts Theraclion SA’s price is currently Overvalued.
Does Theraclion SA pay dividends?
Theraclion SA does not currently pay dividends.
What is Theraclion SA’s EPS estimate?
Theraclion SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theraclion SA have?
Currently, no data Available
What happened to Theraclion SA’s price movement after its last earnings report?
Theraclion SA reported an EPS of -$0.056 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Theraclion SA?
Currently, no hedge funds are holding shares in TCLIF
---
Company Description
Theraclion SA
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
---
Technical Analysis
---